Your browser doesn't support javascript.
loading
FSCN1 as a new druggable target in adrenocortical carcinoma.
Ruggiero, Carmen; Tamburello, Mariangela; Rossini, Elisa; Zini, Silvia; Durand, Nelly; Cantini, Giulia; Cioppi, Francesca; Hantel, Constanze; Kiseljak-Vassiliades, Katja; Wierman, Margaret E; Landwehr, Laura-Sophie; Weigand, Isabel; Kurlbaum, Max; Zizioli, Daniela; Turtoi, Andrei; Yang, Shengyu; Berruti, Alfredo; Luconi, Michaela; Sigala, Sandra; Lalli, Enzo.
Afiliação
  • Ruggiero C; Institut de Pharmacologie Moléculaire et Cellulaire CNRS UMR 7275, 06560, Valbonne, France.
  • Tamburello M; Université Côte d'Azur, 06560, Valbonne, France.
  • Rossini E; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25124, Brescia, Italy.
  • Zini S; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25124, Brescia, Italy.
  • Durand N; Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, 25124, Brescia, Italy.
  • Cantini G; Institut de Pharmacologie Moléculaire et Cellulaire CNRS UMR 7275, 06560, Valbonne, France.
  • Cioppi F; Université Côte d'Azur, 06560, Valbonne, France.
  • Hantel C; Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134, Florence, Italy.
  • Kiseljak-Vassiliades K; Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, AOU Careggi, 50134, Florence, Italy.
  • Wierman ME; Centro di Ricerca e Innovazione sulle Patologie Surrenaliche, AOU Careggi, 50134, Florence, Italy.
  • Landwehr LS; Department of Experimental and Clinical Medicine, University of Florence, 50134, Florence, Italy.
  • Weigand I; Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), 8091, Zürich, Switzerland.
  • Kurlbaum M; Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, 01307, Dresden, Germany.
  • Zizioli D; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, 80045, Aurora, Colorado, USA.
  • Turtoi A; Rocky Mountain Regional Veterans Affairs Medical Center, 80045, Aurora, Colorado, USA.
  • Yang S; Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, 80045, Aurora, Colorado, USA.
  • Berruti A; Rocky Mountain Regional Veterans Affairs Medical Center, 80045, Aurora, Colorado, USA.
  • Luconi M; Division of Endocrinology and Diabetology-Department of Internal Medicine I, University Hospital, University of Würzburg, 97080, Würzburg, Germany.
  • Sigala S; Division of Endocrinology and Diabetology-Department of Internal Medicine I, University Hospital, University of Würzburg, 97080, Würzburg, Germany.
  • Lalli E; Department of Medicine IV, University Hospital Munich, Ludwig-Maximilians-Universität München, 81377, Munich, Germany.
Int J Cancer ; 153(1): 210-223, 2023 07 01.
Article em En | MEDLINE | ID: mdl-36971100
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Carcinoma Adrenocortical Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Carcinoma Adrenocortical Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article